下載本文檔
版權(quán)說明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請進(jìn)行舉報或認(rèn)領(lǐng)
文檔簡介
1、Hotline: 400-820-3792Inhibitors Agonists Screening Librarieswww.MedChemELF3Cat. No.: HY-101486CAS No.: 664969-54-4分式: CHNOS分量: 416.56作靶點(diǎn): -catenin作通路: Stem Cell/Wnt儲存式: Powder -20C 3 years4C 2 yearsIn solvent -80C 6 months-20C 1 month溶解性數(shù)據(jù)體外實(shí)驗(yàn) DMSO : 32 mg/mL (76.82 mM)* means soluble, but saturatio
2、n unknown.Mass Solvent1 mg 5 mg 10 mg Concentration制備儲備液1 mM 2.4006 mL 12.0031 mL 24.0061 mL5 mM 0.4801 mL 2.4006 mL 4.8012 mL10 mM 0.2401 mL 1.2003 mL 2.4006 mL請根據(jù)產(chǎn)品在不同溶劑中的溶解度,選擇合適的溶劑配制儲備液,并請注意儲備液的保存式和期限。體內(nèi)實(shí)驗(yàn)請根據(jù)您的實(shí)驗(yàn)動物和給藥式選擇適當(dāng)?shù)娜芙獍?,配制前請先配制澄清的儲備液,再依次添加助溶?為保證實(shí)驗(yàn)結(jié)果的可靠性,體內(nèi)實(shí)驗(yàn)的作液,建議您現(xiàn)現(xiàn)配,當(dāng)天使;澄清的儲備液可以根據(jù)儲存條件,
3、適當(dāng)保存;以下溶劑前的百分 指該溶劑在您配制終溶液中的體積占):1. 請依序添加每種溶劑: 10% DMSO 40% PEG300 5% Tween-80 45% salineSolubility: 2.5 mg/mL (6.00 mM); Clear solution2. 請依序添加每種溶劑: 10% DMSO 90% (20% SBE-CD in saline)Solubility: 2.5 mg/mL (6.00 mM); Clear solution3. 請依序添加每種溶劑: 10% DMSO 90% corn oil1/2 Master of Small Molecules 您邊的抑
4、制劑師www.MedChemESolubility: 2.5 mg/mL (6.00 mM); Clear solutionBIOLOGICAL ACTIVITY物活性 LF3-Catenin/TCF4相互作的拮抗劑,具有抗腫瘤活性。IC50值為1.65 M。IC50 & Target IC50: 1.65 M (-Catenin/TCF4, AlphaScreen), 1.82 M (-Catenin/TCF4, ELISA) 1體外研究 LF3 inhibits Wnt/-catenin signals in cells with exogenous reporters and in co
5、lon cancer cells withendogenously high Wnt activity. LF3 also suppresses features of cancer cells related to Wnt signaling,including high cell motility, cell-cycle progression, and the overexpression of Wnt target genes. However, LF3does not cause cell death or interfere with cadherin-mediated cell-
6、cell adhesion. Remarkably, the self-renewal capacity of cancer stem cells is blocked by LF3 in concentration-dependent manners 1.體內(nèi)研究 LF3 reduces tumor growth and induces differentiation in a mouse xenograft model of colon cancer. Tumorgrowth is significantly reduced when mice with GFPhigh cells are
7、 treated with LF3 at 50 mg/kg. LF3treatment does not disturb the normal histology of the gut of mice 1.PROTOCOLCell Assay 1 LF3 is dissolved in DMSO to a concentration of 50 mM and diluted with culture medium. Two colon cancercell lines (HCT116 and HT29) and a breast cancer cell line (MCF7) are trea
8、ted with LF3 (0, 30, 60 M) for 24hours and labeled with BrdUrd for 4 to 5 hours to detect proliferating cells 1.MCE has not independently confirmed the accuracy of these methods. They are for reference only.Animal Mice: Unsorted GFPlow and GFPhigh SW480 cells are subcutaneously injected into the bac
9、k skin ofAdministration 1 NOD/SCID mice. Tumor growth is monitored over a period of 45 days. For therapy, LF3 is administered i.v. at50 mg/kg body weight for three rounds over 5 consecutive days, with 2-day breaks 1.MCE has not independently confirmed the accuracy of these methods. They are for refe
10、rence only.戶使本產(chǎn)品發(fā)表的科研獻(xiàn) Biochem Biophys Res Commun. 2019 Aug 27;516(3):819-824.See more customer validations on HYPERLINK / www.MedChemEREFERENCES1. Fang L, et al. A Small-Molecule Antagonist of the -Catenin/TCF4 Interaction Blocks the Self-Renewal of Cancer Stem Cells andSuppresses Tumorigenesis. Cancer Res. 2016 Feb 15;76(4):891-901.McePdfHeight2/2 Master of Small Molecules 您邊的抑制劑師www.MedChemECaution: Product has not been fully
溫馨提示
- 1. 本站所有資源如無特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請下載最新的WinRAR軟件解壓。
- 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
- 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁內(nèi)容里面會有圖紙預(yù)覽,若沒有圖紙預(yù)覽就沒有圖紙。
- 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
- 5. 人人文庫網(wǎng)僅提供信息存儲空間,僅對用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對任何下載內(nèi)容負(fù)責(zé)。
- 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請與我們聯(lián)系,我們立即糾正。
- 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時也不承擔(dān)用戶因使用這些下載資源對自己和他人造成任何形式的傷害或損失。
最新文檔
- 公益廣告制作與發(fā)布行業(yè)投資機(jī)會與風(fēng)險識別及應(yīng)對策略報告
- 小微企業(yè)保險行業(yè)市場需求分析及未來三年行業(yè)預(yù)測報告
- 在線職業(yè)啟蒙教育行業(yè)競爭格局及投資價值分析報告
- 在線編程教育行業(yè)技術(shù)趨勢分析
- 自動駕駛與機(jī)器學(xué)習(xí)行業(yè)影響因素分析
- 人力資源流程再造行業(yè)商業(yè)機(jī)會挖掘與戰(zhàn)略布局策略研究報告
- 虛擬旅游行業(yè)市場突圍建議書
- 武術(shù)俱樂部行業(yè)發(fā)展趨勢及前景展望分析報告
- 生物傳感器行業(yè)相關(guān)項(xiàng)目經(jīng)營管理報告
- 廢棄包裝物處理行業(yè)風(fēng)險投資態(tài)勢及投融資策略指引報告
- SL-T+62-2020水工建筑物水泥灌漿施工技術(shù)規(guī)范
- 中班詩歌《美麗的祖國》課件
- 2023超星爾雅《創(chuàng)新創(chuàng)業(yè)》答案
- 小學(xué)思政課《愛國主義教育》
- 蘇教版小學(xué)科學(xué)三年級上冊全冊完整課件
- 外貿(mào)報關(guān)用發(fā)票、裝箱單、合同、報關(guān)單模板
- 建筑設(shè)計規(guī)范2019
- 慕課跨文化客觀題.docx
- 第十一章 溝通——管理學(xué)(馬工程).ppt
- 15.5串并聯(lián)電路中電流的規(guī)律(內(nèi)含大量flash動畫).ppt
- 七年級上冊-Unit-6-Travelling-around-Asia-課文同步訓(xùn)練
評論
0/150
提交評論